These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Studies shed light on risks and trends in pediatric antipsychotic prescribing. Kuehn BM JAMA; 2010 May; 303(19):1901-3. PubMed ID: 20483961 [No Abstract] [Full Text] [Related]
3. Off-label use of atypical antipsychotics: cause for concern? McKean A; Monasterio E CNS Drugs; 2012 May; 26(5):383-90. PubMed ID: 22448598 [TBL] [Abstract][Full Text] [Related]
10. Practice guidelines and combining atypical antipsychotics. Wilf TJ Am J Psychiatry; 2004 Sep; 161(9):1717-8. PubMed ID: 15337672 [No Abstract] [Full Text] [Related]
11. Treatment of Young People With Antipsychotic Medications in the United States. Olfson M; King M; Schoenbaum M JAMA Psychiatry; 2015 Sep; 72(9):867-74. PubMed ID: 26132724 [TBL] [Abstract][Full Text] [Related]
12. Anxiety disorders and antipsychotic drugs: a pressing need for more research. Breier A Am J Psychiatry; 2011 Oct; 168(10):1012-4. PubMed ID: 21969042 [No Abstract] [Full Text] [Related]
13. When Off-label is Illegal: Implications of Mandating the FDA-approved Protocol for Mifepristone-induced Abortions. Britton L; Bryant A Womens Health Issues; 2015; 25(5):433-5. PubMed ID: 26169217 [No Abstract] [Full Text] [Related]
14. Antipsychotic use among nursing home residents. Briesacher BA; Tjia J; Field T; Peterson D; Gurwitz JH JAMA; 2013 Feb; 309(5):440-2. PubMed ID: 23385262 [No Abstract] [Full Text] [Related]
16. Prescribing optimal drug therapy for older people: sending the right message: comment on "impact of FDA black box advisory on antipsychotic medication use". Rochon PA; Anderson GM Arch Intern Med; 2010 Jan; 170(1):103-6. PubMed ID: 20065206 [No Abstract] [Full Text] [Related]
17. Atypical antipsychotic use among Medicaid-insured children and adolescents: duration, safety, and monitoring implications. Burcu M; Zito JM; Ibe A; Safer DJ J Child Adolesc Psychopharmacol; 2014 Apr; 24(3):112-9. PubMed ID: 24690011 [TBL] [Abstract][Full Text] [Related]
18. Restrictions on pharmaceutical detailing reduced off-label prescribing of antidepressants and antipsychotics in children. Larkin I; Ang D; Avorn J; Kesselheim AS Health Aff (Millwood); 2014 Jun; 33(6):1014-23. PubMed ID: 24889951 [TBL] [Abstract][Full Text] [Related]
19. Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database. Tuchscherer RM; Nair K; Ghushchyan V; Saseen JJ Am J Cardiovasc Drugs; 2015 Feb; 15(1):27-34. PubMed ID: 25348907 [TBL] [Abstract][Full Text] [Related]